(Q44551644)

4 December 2017

title

Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians (English)

1 reference

4 December 2017

1 reference

1 reference

ventricular dysfunction

1 reference

left ventricular dysfunction

inferred from title

1 reference

inferred from title

chronic heart failure

1 reference

Sinéad P McKee

1

1 reference

4 December 2017

Stephen J Leslie

2

1 reference

4 December 2017

John P LeMaitre

3

1 reference

4 December 2017

David J Webb

4

1 reference

4 December 2017

Martin A Denvir

5

1 reference

4 December 2017

publication date

1 August 2003

1 reference

European Journal of Heart Failure

4 December 2017

published in

1 reference

4 December 2017

volume

5

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

549-555

1 reference

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Randomised controlled trial of specialist nurse intervention in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

[Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology--Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceut

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Serious adverse events experienced by patients with chronic heart failure taking spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

The effect of digoxin on mortality and morbidity in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

7 January 2021

Physical training improves skeletal muscle metabolism in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

7 January 2021

Cost effective management programme for heart failure reduces hospitalisation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

7 January 2021

Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2803%2900003-5

7 January 2021

10.1016/S1388-9842(03)00003-5

Identifiers

DOI

1 reference

4 December 2017

1 reference